Understanding the risks and outcomes of gallstone disease and its treatments in older adults
The Natural History of Overall Mortality with Diagnosed Symptomatic Gallstone Disease in the United States: A Sequential Mixed-methods Study Evaluating Emergency, Non-emergency, and No Cholecystectomy
This study looks at how gallstone disease affects people and compares the results of emergency surgeries to planned ones, hoping to find ways to reduce emergency surgeries and improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11142651 on NIH RePORTER |
What this research studies
This research investigates the natural history and outcomes of symptomatic gallstone disease, particularly focusing on the differences between emergency and elective surgeries. It aims to understand how often emergency surgeries occur and their associated mortality rates compared to non-emergency procedures. By analyzing population data, the study seeks to identify factors that could help prevent emergency surgeries and improve patient outcomes. The findings could lead to better management strategies for patients with gallstone disease, potentially reducing the need for emergency interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those aged 65 and above, who have been diagnosed with symptomatic gallstone disease.
Not a fit: Patients who do not have symptomatic gallstone disease or are under the age of 65 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols that reduce the mortality and costs associated with gallstone disease.
How similar studies have performed: Previous research has indicated that understanding the natural history of diseases can lead to significant improvements in treatment outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Peck, Gregory Lance — Rutgers Biomedical and Health Sciences
- Study coordinator: Peck, Gregory Lance
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.